-
Reckless behavior with money can be a warning sign of cognitive decline — and the condition can put people at risk of financial ruin. There are few institutional safeguards in place.
-
In the 18-month trial, people in the early stages of Alzheimer's who received infusions of donanemab showed 35% less decline in thinking skills compared to those given a dummy drug, Lilly announced.
-
Lessons learned in a Mayo Clinic study could lead to treatment or even a cure for Alzheimer's.
-
The AHEAD Study - with participants in the Orlando region - examines whether the newly approved drug lecanemab can prevent or at least delay the appearance of Alzheimer's symptoms.
-
Scientists are digging into why a few people escape the rarest form of Alzheimer's, which is inherited and strikes young.
-
Facilitator Pamela Levin of the Alzheimer's Association said Art Connects ALZ is a relaxing program using watercolors . It's therapeutic but not art therapy or art instruction.
-
Programs assisting people with dementia — and their caregivers — improve quality of life and care. But millions of unpaid family and friend caregivers may not know where or how to find help.
-
A large study found that cutting down on alcohol is a good idea. People who quit drinking also had increased risk of dementia, but researchers cautioned about drawing conclusions from that.
-
Willis family announced Thursday that his previous diagnosis of aphasia has progressed to frontotemporal dementia. The disease can cause issues with speaking and writing.
-
The FDA approved the use of Leqembi in January for patients with mild or early cases of dementia tied to Alzheimer’s. A year’s treatment runs about $26,500, and there are few options outside of self-pay.